Conference abstract · 24 Aug 2015
Short communicationPublished 29 Oct 2021
Radiosensitizer Development Plan for Glioblastoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Glioblastoma is the most prevalent type of primary brain cancer and has a bad prognosis. New agents are desperately needed, yet nearly every Phase III study of GBM patients conducted in the last 25 years has failed to show a significant improvement in outcomes. The Glioblastoma Working Group (GBM WG) of the National Cancer Institute's Clinical Trials and Translational Research Advisory Committee (CTAC) highlighted five main areas of research in 2019 that are anticipated to be significant in the development of new GBM therapeutics. Optimizing radioresponse for GBM in situ was one of them. The inclusion of a radiosensitizer to improve the therapeutic ratio by increasing tumour sensitivity while having low to no effect on normal tissue is one such technique for increasing radiation efficacy. Although the bulk of studies involving radiosensitizers have failed in the past, they do provide valuable insight into what is needed to produce agents more quickly. Improved target selection is required for a medicine to deliver maximum benefit, and after that target has been discovered, it must be verified in preclinical research
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Aug 2015
Epigenetics and treatment planning for primary glioblastoma
Conference abstract · 15 Jun 2020
The international debate on the antagonism between the RNA binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development
Conference abstract · 3 Dec 2018
Antagonism between the RNA binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development
Conference abstract · 3 Oct 2018
Antagonism between the RNA binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development
More from this journal
The newest in International Journal of Clinical Skills.
Article · 22 Oct 2026
Benign Hybrid Lesions of the Jaws: A Systematic Review of the Literature
Article · 7 May 2026
Comparative Clinical Effectiveness and Biomechanical Analysis of Suction-Based Anti-Choking Devices (Willnice and LifeVac) Versus the Heimlich Maneuver in Adult Emergency Airway Obstruction
Article · 25 Dec 2024
The Cervical Lymphadenopathy: Could it be prostate cancer?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Skills
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Hazel Grace”
